506 POSTER The apogenic anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in breast and pancreatic cancer and targets cancer stem cells in acute myeloid leukemia

J.Menendez; L.Jin; A.G.Poeppl; K.OReilly; R.H.Brunet; J.Grabell; A.K.Gupta; J.E.Dick; D.S.Pereira; D.S.Young

首页> 外文期刊>European Journal of Cancer Supplements >506 POSTER The apogenic anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in breast and pancreatic cancer and targets cancer stem cells in acute myeloid leukemia

【24h】

506 POSTER The apogenic anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in breast and pancreatic cancer and targets cancer stem cells in acute myeloid leukemia

机译：506 POSTER致癌性抗CD9抗体AR40A746.2.3抑制乳腺癌和胰腺癌中的肿瘤生长，并靶向急性髓样白血病中的癌症干细胞

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2008年第12期|共1页
作者
J.Menendez; L.Jin; A.G.Poeppl; K.OReilly; R.H.Brunet; J.Grabell; A.K.Gupta; J.E.Dick; D.S.Pereira; D.S.Young;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 506 POSTER The apogenic anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in breast and pancreatic cancer and targets cancer stem cells in acute myeloid leukemia [J] . J.Menendez, L.Jin, A.G.Poeppl, European Journal of Cancer Supplements . 2008,第12期

机译：506 POSTER致癌性抗CD9抗体AR40A746.2.3抑制乳腺癌和胰腺癌中的肿瘤生长，并靶向急性髓样白血病中的癌症干细胞
2. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer [J] . Ogier Charline, Colombo Pierre-Emmanuel, Bousquet Corinne, Cancer letters . 2018,第期

机译：靶向肿瘤细胞中的NRG1 / HER3途径和抗Neuregulin 1抗体的癌症相关的成纤维细胞抑制胰腺癌前临床前模型中的肿瘤生长
3. 521 POSTER A monoclonal antibody targeting the breast cancer stem cell marker melanoma-associated chondroitin sulfate proteoglycan improves survival and demonstrates anti-tumor activity in vivo [J] . A.K.Gupta, A.Ferry, M.Amoozgar, European Journal of Cancer Supplements . 2008,第12期

机译：521 POSTER靶向乳腺癌干细胞标志物黑色素相关硫酸软骨素蛋白聚糖的单克隆抗体，在体内可提高生存率并表现出抗肿瘤活性
4. Antibody-targeting of Drug-loaded Micelles to Acute Myeloid Leukemia Cells [C] . Michael P. Baranello, Steven Tau, Danielle S.W. Benoit Society for Biomaterials annual meeting and exposition . 2015

机译：载药胶束针对急性髓样白血病细胞的抗体靶向。
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo [O] . Theodora Stivarou, Dimitris Stellas, Georgia Vartzi, 2016

机译：在乳腺癌干细胞中靶向高表达的细胞外HSP90可在体内外抑制肿瘤生长
7. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer [O] . Charline Ogier, Pierre-Emmanuel Colombo, Corinne Bousquet, 2018

机译：靶向肿瘤细胞中的NRG1 / HER3途径和抗Neuregulin 1抗体的癌症相关的成纤维细胞抑制胰腺癌前临床前模型中的肿瘤生长
8. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

506 POSTER The apogenic anti-CD9 antibody, AR40A746.2.3, inhibits tumor growth in breast and pancreatic cancer and targets cancer stem cells in acute myeloid leukemia

著录项

相似文献

相关主题

期刊订阅